Table 1.
Summary Data of CT Biomarkers According to Clinical Outcomes | |||||
---|---|---|---|---|---|
CT Biomarker | Total Cohort (n=9223) | CV Event | Death | ||
Yes (n=1831) | No (n=7392) | Yes (n=549) | No (n=8674) | ||
AoCa (Ag) | |||||
Mean | 699 | 1628 | 469 | 2471 | 587 |
Median | 59 | 449 | 31 | 873 | 48 |
IQR | 0–493 | 38–1945 | 0–313 | 131–3541 | 0–428 |
Muscle HU | |||||
Mean | 28.9 | 25.4 | 29.8 | 20.8 | 29.4 |
Median | 31 | 27 | 31 | 22 | 31 |
IQR | 22–38 | 17–35 | 23–38 | 12–31 | 23–38 |
V/S Fat Ratio | |||||
Mean | 0.91 | 1.13 | 0.58 | 1.22 | 0.89 |
Median | 0.72 | 0.94 | 0.68 | 0.98 | 0.71 |
IQR | 0.5–1.2 | 0.6–1.4 | 0.5–1.1 | 0.7–1.5 | 0.5–1.1 |
Liver HU | |||||
Mean | 55.4 | 54.1 | 55.7 | 53.6 | 55.5 |
Median | 58 | 56 | 58 | 56 | 58 |
IQR | 52–62 | 50–61 | 52–62 | 50–60 | 52–62 |
L1 HU | |||||
Mean | 171.2 | 159.0 | 174.2 | 150.9 | 172.4 |
Median | 168 | 156 | 171 | 146 | 169 |
IQR | 142–197 | 128–186 | 146–200 | 113–180 | 144–198 |
CV = cardiovascular; AoCa = aortic calcification; Ag = Agatston score; HU = Hounsfield units; V/S = visceral-tosubcutaneous; IQR = interquartile ratio; Subsequent CV events defined as acute MI, CVA, CHF, or death
All comparisons of CT biomarkers with versus without events were statistically significant (p<0.001)